Effects of Atypical Protein Kinase C Inhibitor (DNDA) on Lung Cancer Proliferation and Migration by PKC-ι/FAK Ubiquitination Through the CBL-B Pathway
OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s224866
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2020
Authors
Publisher
Informa UK Limited